Broadcom (AVGO) Declares $0.59 Quarterly Dividend; 0.9% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Broadcom Limited (AVGO) PT Raised to $295 at Truist Securities, 'Buy the near-term weakness'
June 6, 2025 7:06 AM EDTTruist Securities analyst William Stein raised the price target on Broadcom Limited (NASDAQ: AVGO) to $295.00 (from $267.00) while maintaining a Buy rating.
The analyst comments "Buy the near-term weakness. AVGO posted very modest upside to CQ1 (Apr) results, and CQ2 (July) guidance.... More
Broadcom Limited (AVGO) PT Raised to $325 at JPMorgan
June 6, 2025 5:16 AM EDTJPMorgan analyst Harlan Sur raised the price target on Broadcom Limited (NASDAQ: AVGO) to $325.00 (from $250.00) while maintaining a Overweight rating.
The analyst comments "We see the recent ruling from the U.S. District Court for the District of Delaware in favor of ACAD regarding its 721 formulation patent for Nuplazid (pimavanserin) on both infringement and validity arguments against Aurobindo Pharma and other ANDA filers (see document here) as a clear positive. Note that the 721 patent provides protection for the Nuplazid 34mg capsule formulation into 2038. We believe it is logical to assume the parties... More
Broadcom Limited (AVGO) PT Raised to $270 at Morgan Stanley
June 6, 2025 4:59 AM EDTMorgan Stanley analyst Joseph Moore raised the price target on Broadcom Limited (NASDAQ: AVGO) to $270.00 (from $260.00) while maintaining a Overweight rating.
The analyst comments "Thoughts on the stock: AVGO seems the most uncontroversial of the AI names ever since the 2027 SAM raised longer term expectations. That makes sense... More
Broadcom Limited (AVGO) PT Raised to $304 at Evercore ISI, 'We’re Still Buyers'
June 6, 2025 4:54 AM EDTEvercore ISI analyst Mark Lipacis raised the price target on Broadcom Limited (NASDAQ: AVGO) to $304.00 (from $267.00) while maintaining a Outperform rating.
The analyst comments "Were Still Buyers of AVGO after an in-line AprQ print and implied EPS outlook that is $0.01 below consensus. AI revs... More
Broadcom Limited (AVGO) PT Raised to $315 at KeyBanc
June 6, 2025 4:49 AM EDTKeyBanc analyst John Vinh raised the price target on Broadcom Limited (NASDAQ: AVGO) to $315.00 (from $275.00) while maintaining a Overweight rating.
The analyst comments "AVGO reported solid F2Q (Apr) results and provided mixed F3Q (Jul) guidance (higher revs, lower... More
